BFPW
UTHR icon

BOK Financial Private Wealth’s United Therapeutics UTHR Stock Holding History

BOK Financial Private Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22
Closed -$6.78K – 499
2025
Q1 		$6.78K Buy
+22
New +$7.54K ﹤0.01% 412
2023
Q2 		– Sell
-6
Closed -$1.34K – 461
2023
Q1 		$1.34K Buy
+6
New +$1.48K ﹤0.01% 450

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BOK Financial Private Wealth's UTHR Position: Q2 2025 in Review

BOK Financial Private Wealth sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 22 shares — an estimated $6.78K sold.

BOK Financial Private Wealth first reported a position in UTHR in Q1 2023 and held it in 2 quarters. The position peaked at $6.78K in Q1 2025. 670 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • BOK Financial Private Wealth reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • BOK Financial Private Wealth sold 22 United Therapeutics shares in Q2 2025, an estimated $6.78K.
  • BOK Financial Private Wealth first reported a position in United Therapeutics in Q1 2023 and held it in 2 quarters.
  • BOK Financial Private Wealth's United Therapeutics position peaked at $6.78K in Q1 2025.
  • 670 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on BOK Financial Private Wealth's 13F filing for Q2 2025, filed 7 Aug 2025.